1. Home
  2. LC vs NVCR Comparison

LC vs NVCR Comparison

Compare LC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingClub Corporation

LC

LendingClub Corporation

HOLD

Current Price

$14.49

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.23

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LC
NVCR
Founded
2006
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
LC
NVCR
Price
$14.49
$10.23
Analyst Decision
Buy
Buy
Analyst Count
6
6
Target Price
$22.67
$28.08
AVG Volume (30 Days)
1.4M
1.0M
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
157.78
21.79
EPS
1.16
N/A
Revenue
$314,702,000.00
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
$14.53
$6.74
P/E Ratio
$12.67
N/A
Revenue Growth
N/A
8.28
52 Week Low
$8.34
$9.82
52 Week High
$21.67
$20.05

Technical Indicators

Market Signals
Indicator
LC
NVCR
Relative Strength Index (RSI) 48.40 35.78
Support Level $13.36 N/A
Resistance Level $15.12 $14.11
Average True Range (ATR) 0.60 0.54
MACD 0.16 -0.14
Stochastic Oscillator 72.95 6.04

Price Performance

Historical Comparison
LC
NVCR

About LC LendingClub Corporation

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: